Meiji Yasuda Asset Management Co Ltd. lessened its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 16.3% in the second quarter, Holdings Channel.com reports. The fund owned 14,686 shares of the semiconductor company’s stock after selling 2,863 shares during the quarter. Meiji Yasuda Asset Management Co Ltd.’s holdings in Synopsys were worth $8,739,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in SNPS. ORG Partners LLC grew its stake in shares of Synopsys by 600.0% during the second quarter. ORG Partners LLC now owns 42 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 36 shares during the period. University of Texas Texas AM Investment Managment Co. acquired a new position in Synopsys in the fourth quarter valued at about $28,000. Chris Bulman Inc bought a new position in Synopsys during the second quarter worth about $30,000. Jones Financial Companies Lllp grew its position in shares of Synopsys by 233.3% during the 4th quarter. Jones Financial Companies Lllp now owns 60 shares of the semiconductor company’s stock worth $31,000 after buying an additional 42 shares during the period. Finally, Fortitude Family Office LLC increased its stake in shares of Synopsys by 66.7% in the 2nd quarter. Fortitude Family Office LLC now owns 60 shares of the semiconductor company’s stock valued at $36,000 after acquiring an additional 24 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
SNPS stock opened at $502.25 on Wednesday. The stock has a market capitalization of $76.95 billion, a P/E ratio of 54.59, a P/E/G ratio of 3.23 and a beta of 1.08. Synopsys, Inc. has a fifty-two week low of $440.62 and a fifty-two week high of $629.38. The business has a 50-day moving average of $532.47 and a 200-day moving average of $558.06.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on SNPS. JPMorgan Chase & Co. lifted their price objective on shares of Synopsys from $655.00 to $685.00 and gave the stock an “overweight” rating in a research note on Thursday, August 22nd. Robert W. Baird lifted their price target on shares of Synopsys from $661.00 to $663.00 and gave the stock an “outperform” rating in a research report on Thursday, August 22nd. Needham & Company LLC reissued a “buy” rating and issued a $640.00 price target on shares of Synopsys in a report on Thursday, August 22nd. Piper Sandler reaffirmed an “overweight” rating and set a $687.00 price objective on shares of Synopsys in a research note on Thursday, August 22nd. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $635.00 target price on shares of Synopsys in a report on Friday, August 23rd. Eleven equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Synopsys presently has an average rating of “Buy” and a consensus target price of $630.09.
Insider Activity at Synopsys
In related news, CEO Sassine Ghazi sold 10,293 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $553.89, for a total transaction of $5,701,189.77. Following the completion of the transaction, the chief executive officer now directly owns 62,568 shares of the company’s stock, valued at $34,655,789.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, insider Geus Aart De sold 8,158 shares of the business’s stock in a transaction on Thursday, June 27th. The shares were sold at an average price of $602.59, for a total transaction of $4,915,929.22. Following the transaction, the insider now directly owns 106,983 shares in the company, valued at $64,466,885.97. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Sassine Ghazi sold 10,293 shares of the stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $553.89, for a total transaction of $5,701,189.77. Following the completion of the sale, the chief executive officer now owns 62,568 shares of the company’s stock, valued at approximately $34,655,789.52. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 73,687 shares of company stock valued at $44,616,637. 0.66% of the stock is owned by insiders.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- Health Care Stocks Explained: Why You Might Want to Invest
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Buy P&G Now, Before It Sets A New All-Time High
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.